Cited by 32Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD

Open access
Vergallo, Andrea, Houot, Marion, Cavedo, Enrica, Lemercier, Pablo, Vanmechelen, Eugeen, De Vos, Ann, Habert, Marie‐Odile, Potier, Marie‐Claude +5 more·2019·Alzheimer's & Dementia

Abstract

INTRODUCTION: Successful development of effective β-site amyloid precursor protein cleaving enzyme 1 (BACE1)-targeted therapies for early stages of Alzheimer's disease requires biomarker-guided intervention strategies. METHODS: We investigated whether key biological factors such as sex, apolipoprotein E (APOE ε4) allele, and age affect longitudinal plasma BACE1 concentrations in a large monocenter cohort of individuals at risk for Alzheimer's disease. We explored the relationship between plasma BACE1 concentrations and levels of brain amyloid-β (Aβ) deposition, using positron emission tomography global standard uptake value ratios. RESULTS: Baseline and longitudinal mean concentrations of plasma BACE1 were significantly higher in women than men. We also found a positive significant impact of plasma BACE1 on baseline Aβ-positron emission tomography global standard uptake value ratios. DISCUSSION: Our results suggest a sexual dimorphism in BACE1-related upstream mechanisms of brain Aβ production and deposition. We argue that plasma BACE1 should be considered in further biomarker validation and qualification studies as well as in BACE1 clinical trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2019.07.001

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Plasma BACE1 concentrations are associated with amyloid-PET quantitative measures in cognitively healthy individuals at risk for AD.

    “A recent study showed an association between plasma BACE1 concentrations and amyloid-positron emission tomography quantitative measures in a cohort of cognitively healthy individuals at risk for AD (86).”

    From The β-Secretase BACE1 in Alzheimer’s Disease (2021) · cites this paper as [86]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Patrizia A. Chiesa (Paris), Jean-Christophe Corvol (Paris), Augusto Claudio Cuello (Montr eal), Jeffrey L. Cummings (Las Vegas), Herman Depypere (Gent), Bruno Dubois (Paris), Andrea Duggento (Rome), Enzo Emanuele (Rob- bio), Valentina Escott-Price (Cardiff), Howard Federoff (Ir- vine), Maria Teresa Ferretti (Z€ urich), Massimo Fiandaca (Irvine), Richard A. Frank (Malvern), Francesco Garaci (Rome), Hugo Geerts (Berwyn), Filippo S. Giorgi (Pisa), Edward J. Goetzl (San Francisco), Manuela Graziani (Roma), Marion Haberkamp (Bonn), Marie-Odile Habert (Paris), Harald Hampel (Paris), Karl Herholz (Manchester), Felix Hernandez (Madrid), Dimitrios Kapogiannis (Balti- more), Eric Karran (Cambridge), Steven J. Kiddle (Cam- bridge), Seung H. Kim (Seoul), Yosef Koronyo (Los Angeles), Maya Koronyo-Hamaoui (Los Angeles), Todd Langevin (Minneapolis-Saint Paul), St ephane Leh ericy (Paris), Pablo Lemercier (Paris), Alejandro Luc ıa (Madrid), Simone Lista (Paris), Jean Lorenceau (Paris), Dalila Mango (Rome), Mark Mapstone (Irvine), Christian Neri (Paris), Robert Nistic o (Rome), Sid E. O'Bryant (Fort Worth), Gio- vanni Palermo (Pisa), George Perry (San Antonio), Craig Ritchie (Edinburgh), Simone Rossi (Siena), Amira Saidi (Rome), Emiliano Santarnecchi (Siena), Lon S. Schneider (Los Angeles), Olaf Sporns (Bloomington), Nicola Toschi (Rome), Steven R. Verdooner (Sacramento), Andrea Ver- gallo (Paris), Nicolas Villain (Paris), Lindsay A. Weliko- vitch (Montr eal), Janet Woodcock (Silver Spring), Erfan Younesi (Esch-sur-Alzette). References
  2. Chouraki V, van der Lee SJ, Grenier-Boley B, Simino J, Adams H, Tosto G, et al. Genome-wide association study links APOEε4 and BACE1 variants with plasma amyloid b levels. BioRxiv 2017:194266.

Cited by

Sorted by citations

Authors
Vergallo, A., Houot, M., Cavedo, E., Lemercier, P., Vanmechelen, E., De Vos, A., Habert, M., Potier, M., Dubois, B., Lista, S., Hampel, H., INSIGHT‐preAD study group, & (APMI), A. P. M. I.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • ADx NeuroSciences (BE)
  • ADx NeuroSciences NV Ghent Belgium
  • Sorbonne Université (FR)
Corresponding author
Vergallo, Andrea
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2019-10
Volume
15
Issue
10
Pages
1274-1285
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2980640997
Cited by
32
References
37
Citations by year
2026: 4 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 3
FWCI
2.40
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by-nc-nd)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, other-oa)
  • HAL (submittedVersion, cc-by-nc)
  • HAL (submittedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by-nc-nd)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by-nc-nd)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
  • Use Siena air (University of Siena) (submittedVersion, cc-by-nc-nd)
Funders
  • AXA Research Fund
  • Agence Nationale de la Recherche
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
BACE1
MeSH terms
Aged, Alzheimer Disease, Apolipoproteins E, Brain, Cognition, Female, Humans, Male, Sex Factors, Biomarkers, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Positron-Emission Tomography, Amyloid Precursor Protein Secretases, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review